Skip to main content
BIOME AUSTRALIA LIMITED logo

BIOME AUSTRALIA LIMITED — Investor Relations & Filings

Ticker · BIO ISIN · AU0000184137 ASX Manufacturing
Open in API
Filings indexed 302 across all filing types
Latest filing 2026-03-19 Share Issue/Capital Cha…
Country AU Australia
Listing ASX BIO

About BIOME AUSTRALIA LIMITED

https://www.biomeaustralia.com

Biome Australia Limited is a microbiome health company specializing in the development and distribution of evidence-based probiotics and complementary medicines. The company focuses on translating microbiome science into accessible healthcare solutions through its flagship brand, Activated Probiotics. Its product portfolio consists of condition-specific formulations designed to address various health areas, including digestive health, immune system support, bone density, and mental wellbeing via psychobiotics. Biome Australia prioritizes clinical research and collaborates with global experts to ensure the efficacy of its formulations. The company’s distribution strategy centers on a network of community pharmacies and independent health practitioners, providing professional-grade supplements to the retail and clinical markets.

Recent filings

Filing Released Lang Actions
Application for quotation of securities - BIO 7 pages 20.8KB
Share Issue/Capital Change Classification · 100% confidence The document is an Appendix 2A form, which is a standard ASX (Australian Securities Exchange) form used for the application for quotation of securities. It details the issuance and quotation of securities under an employee incentive scheme, including the number of securities, issue date, and related information. The document is an announcement related to capital changes, specifically the quotation of new securities issued. It is not a financial report, earnings release, or management discussion. It fits the category of announcements regarding new share issues or capital changes. Therefore, the appropriate classification is Share Issue/Capital Change (SHA). The document length and content confirm it is a full announcement, not just a brief notice or a report publication announcement.
2026-03-19 English
Secondary Trading Notice 1 page 135.5KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 20 March 2026 regarding the issuance of shares on the exercise of options and the related secondary trading notice pursuant to section 708A(5) of the Corporations Act 2001. It details compliance with disclosure requirements and exemptions for the resale of shares. The content is a regulatory announcement about share issuance and trading status, not a full financial report, earnings release, or management discussion. The document length is short (1697 characters) and it serves as a formal notification to the market rather than a detailed report. Therefore, it fits best under Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes such as share issuances.
2026-03-19 English
Proposed issue of securities - BIO 5 pages 17.2KB
Capital/Financing Update Classification · 95% confidence The document is titled 'Appendix 3B - Proposed issue of securities' and details a proposed issue of securities by Biome Australia Limited. It includes specifics about the number of securities, the nature of the issue (placement or other type), the proposed issue date, and compliance with ASX Listing Rules. The document is an announcement about a capital raising or securities issuance event rather than a financial report or detailed analysis. It does not contain financial statements or management discussion but focuses on the issuance of new shares and related regulatory compliance. Therefore, this fits the category of Capital/Financing Update (CAP). The document length is over 6000 characters, indicating it is a full announcement rather than a brief notice or report publication announcement.
2026-03-18 English
Application for quotation of securities - BIO 7 pages 21.0KB
Share Issue/Capital Change Classification · 100% confidence The document is an Appendix 2A form, which is a standard ASX (Australian Securities Exchange) announcement used for the application for quotation of securities. It details the issuance and quotation of new securities resulting from options being exercised or convertible securities being converted. The document includes specifics such as the number of securities, issue dates, issue prices, and the class of securities. It is not a financial report, earnings release, or management discussion, but rather a formal announcement related to capital changes and securities quotation on the exchange. Therefore, it fits the category of Share Issue/Capital Change (SHA). The document length and content confirm it is a full announcement, not just a brief notice or report publication announcement.
2026-03-16 English
Secondary Trading Notice 1 page 134.8KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 17 March 2026 regarding the issuance of 875,000 fully paid ordinary shares on the exercise of options. It references compliance with the Corporations Act 2001, specifically section 708A(5), which relates to secondary trading notices and exemptions for on-sale of securities without disclosure. The document is short (1690 characters) and serves as a formal notification to the ASX about the share issuance and the legal basis for the exemption from disclosure requirements. It does not contain financial statements, detailed financial data, or management discussion. It is not a report but a regulatory announcement about a capital event (share issuance). Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2026-03-16 English
Change of Director's Interest Notice 2 pages 335.1KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details the change in securities holdings of a company director, including the number of shares held before and after the change, the nature of the interest (direct or indirect), and the value of the transaction. The document is a formal notification of a director's personal share transactions. It does not contain financial statements, management discussion, or other report content. This matches the definition of 'Director's Dealing' filings, which report personal share transactions by company directors and executives (insider trades). The document length is 3470 characters, which is consistent with a notice rather than a full report. Therefore, the correct classification is DIRS.
2026-03-12 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.